[fcb5af]: / literature / by_gene / CBLB.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 29707316 10.21037/jtd.2018.02.31 2022 Single nucleotide polymorphisms of casitas B-lineage lymphoma proto-oncogene-b predict outcomes of patients with advanced non-small cell lung cancer after first-line platinum based doublet chemotherapy. CBLB
2 32158232 10.2147/OTT.S224866 2022 Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway. CBLB
3 33882749 10.1177/24725552211000675 2022 In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors. CBLB
4 34272310 10.1136/jitc-2021-002889 2022 Tumor rejection in <i>Cblb</i> <sup>-/-</sup> mice depends on IL-9 and Th9 cells. CBLB
5 34836490 10.1080/15548627.2021.1997053 2022 HYPK coordinates degradation of polyneddylated proteins by autophagy. CBLB
6 35181779 10.1158/2326-6066.CIR-20-0973 2022 Overproduction of IFNγ by Cbl-b-Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity. CBLB
7 35288194 10.1016/j.ejphar.2022.174876 2022 Cbl-b modulated TrkA ubiquitination and function in the dorsal root ganglion of mice. CBLB
8 35733270 10.1073/pnas.2201490119 2022 IFT80 negatively regulates osteoclast differentiation via association with Cbl-b to disrupt TRAF6 stabilization and activation. CBLB
9 27371568 10.1074/jbc.A113.529925 2021 Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) in response to high calorie diet intake. CBLB
10 31663116 10.1002/jcp.29338 2021 miR-22-3p enhances the intrinsic regenerative abilities of primary sensory neurons via the CBL/p-EGFR/p-STAT3/GAP43/p-GAP43 axis. CBLB
11 32373983 10.26355/eurrev_202004_21027 2021 The effect of Casitas b-lineage lymphoma b on regulating T follicular helper in lupus nephritis. CBLB
12 33625672 10.1007/s12094-021-02569-x 2021 Hypoxia-mediated down-regulation of miRNAs' biogenesis promotes tumor immune escape in bladder cancer. CBLB
13 33741730 10.1136/jitc-2020-001975 2021 <i>CBLB</i> ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy. CBLB
14 33848699 10.1016/j.bmc.2021.116130 2021 An affinity prediction approach for the ligand of E3 ligase Cbl-b and an insight into substrate binding pattern. CBLB
15 34038132 10.1021/acs.jnatprod.1c00367 2021 Sinularamides A-G, Terpenoid-Derived Spermidine and Spermine Conjugates with Casitas B-Lineage Lymphoma Proto-Oncogene B (Cbl-b) Inhibitory Activities from a <i>Sinularia</i> sp. Soft Coral. CBLB
16 34048740 10.1016/j.ejphar.2021.174205 2021 BDNF modulated KCC2 ubiquitylation in spinal cord dorsal horn of mice. CBLB
17 34535769 10.1038/s41388-021-02012-z 2021 Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia. CBLB
18 27446403 10.3892/ol.2016.4730 2020 Cbl-b promotes cell detachment via ubiquitination of focal adhesion kinase. CBLB
19 30442330 10.1016/j.cellimm.2018.11.002 2020 Regulation of immune responses by E3 ubiquitin ligase Cbl-b. CBLB
20 30452556 10.1093/eurheartj/ehy714 2020 Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death. CBLB
21 31056398 10.1016/j.ccell.2019.03.014 2020 Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality. CBLB
22 31531847 10.1002/eji.201948204 2020 TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b. CBLB
23 31790392 10.1371/journal.pbio.3000554 2020 Dynamic trafficking and turnover of JAM-C is essential for endothelial cell migration. CBLB
24 32154175 10.3389/fonc.2020.00181 2020 miR-1323 Promotes Cell Migration in Lung Adenocarcinoma by Targeting Cbl-b and Is an Early Prognostic Biomarker. CBLB
25 29205205 10.1038/tpj.2017.41 2019 Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistance. CBLB
26 29513566 10.1152/ajpcell.00184.2017 2019 Reactive oxygen species upregulate expression of muscle atrophy-associated ubiquitin ligase Cbl-b in rat L6 skeletal muscle cells. CBLB
27 29729186 10.1002/hep.30073 2019 CD2-Associated Protein Contributes to Hepatitis C, Virus Propagation and Steatosis by Disrupting Insulin Signaling. CBLB
28 29938552 10.1177/0300060518770955 2019 Isoflurane decreases interleukin-2 production by increasing c-Cbl and Cbl-b expression in rat peripheral blood mononuclear cells. CBLB
29 30021515 10.1186/s12871-018-0555-z 2019 Increased expression of the Cbl family of E3 ubiquitin ligases decreases Interleukin-2 production in a rat model of peripheral neuropathy. CBLB
30 30024968 10.1371/journal.ppat.1007111 2019 Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB. CBLB
31 30402490 10.1155/2018/6728128 2019 Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion. CBLB
32 28970470 10.1038/s41467-017-00830-y 2018 NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia. CBLB
33 28972304 10.1002/1878-0261.12140 2018 DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells. CBLB
34 25351606 10.1111/1756-185X.12509 2017 Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells. CBLB
35 26732495 10.1016/j.cllc.2015.11.008 2017 Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer. CBLB
36 27039262 10.1016/j.jid.2016.03.024 2017 Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome. CBLB
37 27432944 10.1084/jem.20151932 2017 E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor-mediated antifungal innate immunity. CBLB
38 27685907 2017 Cbl-b regulates the sensitivity of cetuximab through ubiquitin-proteasome system in human gastric cancer cells. CBLB
39 28100467 10.1242/dev.138164 2017 An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance. CBLB
40 28940360 10.1111/cei.13054 2017 Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus. CBLB
41 25952305 10.1002/humu.22809 2016 Molecular Diversity and Associated Phenotypic Spectrum of Germline CBL Mutations. CBLB
42 26087197 10.18632/oncotarget.4382 2016 The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis. CBLB
43 26342078 10.1074/jbc.M115.661413 2016 Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b). CBLB
44 26416283 10.4049/jimmunol.1501200 2016 Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation. CBLB
45 26583948 10.1164/rccm.201502-0250OC 2016 Small Molecule T315 Promotes Casitas B-Lineage Lymphoma-Dependent Degradation of Epidermal Growth Factor Receptor via Y1045 Autophosphorylation. CBLB
46 24614797 10.1507/endocrj.ej14-0048 2015 Ubiquitin ligase Cbl-b and obesity-induced insulin resistance. CBLB
47 24632608 10.1038/onc.2014.22 2015 MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy. CBLB
48 24875217 10.4161/cc.29213 2015 E3 ubiquitin ligase Cbl-b in innate and adaptive immunity. CBLB
49 25261476 10.4049/jimmunol.1303077 2015 A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function. CBLB
50 25285640 10.1016/j.bbrc.2014.09.125 2015 Cbl regulates the activity of SIRT2. CBLB
51 25691332 10.1111/febs.13238 2015 Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B. CBLB
52 25701378 10.1007/s13277-015-3232-6 2015 Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway. CBLB
53 25829233 10.1016/j.clim.2015.03.018 2015 Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720. CBLB
54 25891013 10.1002/art.39163 2015 The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome. CBLB
55 26112603 10.1016/j.febslet.2015.06.015 2015 E3 ubiquitin ligase Cbl-b suppresses human ORMDL3 expression through STAT6 mediation. CBLB
56 24161672 10.1016/j.febslet.2013.10.007 2014 Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells. CBLB
57 24229686 2014 Cbl-b and PI3K/Akt pathway are differently involved in oxygen-glucose deprivation preconditioning in PC12 cells. CBLB
58 24451368 10.1074/jbc.M113.529925 2014 Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake. CBLB
59 24553136 10.1038/nature12998 2014 The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. CBLB
60 24651487 10.1371/journal.pone.0089792 2014 Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes. CBLB
61 22456178 10.1016/j.ejca.2012.03.005 2013 TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells. CBLB
62 23280105 10.1002/art.37833 2013 Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus. CBLB
63 23349502 10.2337/db12-0677 2013 Cbl-b is a critical regulator of macrophage activation associated with obesity-induced insulin resistance in mice. CBLB
64 23663663 10.1111/febs.12333 2013 Multimeric and differential binding of CIN85/CD2AP with two atypical proline-rich sequences from CD2 and Cbl-b*. CBLB
65 23684068 10.1016/j.jaci.2013.03.046 2013 T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation. CBLB
66 23749633 10.4049/jimmunol.1202068 2013 T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells. CBLB
67 22072526 10.1002/gcc.20949 2012 Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia. CBLB
68 22884570 10.1016/j.febslet.2012.07.067 2012 Cbl-b-dependent degradation of FLIP(L) is involved in ATO-induced autophagy in leukemic K562 and gastric cancer cells. CBLB
69 20038312 2011 [Expression of c-Cbl, Cbl-b, and epidermal growth factor receptor in gastric carcinoma and their clinical significance]. CBLB
70 21248250 10.4049/jimmunol.1003390 2011 Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions. CBLB
71 21645455 10.3779/j.issn.1009-3419.2011.06.17 2011 [Expressions of c-Cbl, Cbl-b and EGFR and its role of prognosis in NSCLC]. CBLB
72 20668237 10.1073/pnas.1009209107 2010 T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency. CBLB
73 20805496 10.1073/pnas.1007575107 2010 Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells. CBLB
74 20890046 10.1172/JCI41991 2010 Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice. CBLB
75 19343001 10.1097/CAD.0b013e3283160fd6 2009 PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. CBLB
76 19549983 10.1126/scisignal.276pe38 2009 Activation of T cells: releasing the brakes by proteolytic elimination of Cbl-b. CBLB
77 19549985 10.1126/scisignal.2000046 2009 PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation. CBLB
78 18201552 10.1016/j.bbrc.2008.01.032 2008 Identification and functional analysis of CBLB mutations in type 1 diabetes. CBLB
79 18227156 10.1128/MCB.01505-07 2008 T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. CBLB
80 18832689 10.4049/jimmunol.181.8.5331 2008 Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion. CBLB
81 17038529 10.1182/blood-2006-03-011759 2007 ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. CBLB
82 17259398 10.2337/db06-1027 2007 Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat. CBLB
83 17364027 10.1172/JCI29472 2007 Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. CBLB
84 17391982 10.1016/j.smim.2007.02.004 2007 Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b. CBLB
85 17403934 10.1084/jem.20061699 2007 Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells. CBLB
86 17878343 10.4049/jimmunol.179.7.4473 2007 Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B. CBLB
87 17045823 10.1016/j.immuni.2006.08.021 2006 Establishment of the major compatibility complex-dependent development of CD4+ and CD8+ T cells by the Cbl family proteins. CBLB
88 15629882 10.1189/jlb.0904524 2005 CBLB variants in type 1 diabetes and their genetic interaction with CTLA4. CBLB
89 15661906 10.4049/jimmunol.174.3.1472 2005 Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b. CBLB
90 15897618 10.1538/expanim.54.111 2005 Identification of a major gene responsible for type 1 diabetes in the Komeda diabetes-prone rat. CBLB
91 11591765 10.4049/jimmunol.167.8.4405 2001 CXCR3 expression on CD34(+) hemopoietic progenitors induced by granulocyte-macrophage colony-stimulating factor: II. Signaling pathways involved. CBLB